Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EW9Y | ISIN: US74006W2070 | Ticker-Symbol:
NASDAQ
06.06.25 | 16:24
44,470 US-Dollar
+5,06 % +2,140
1-Jahres-Chart
PRAXIS PRECISION MEDICINES INC Chart 1 Jahr
5-Tage-Chart
PRAXIS PRECISION MEDICINES INC 5-Tage-Chart

Aktuelle News zur PRAXIS PRECISION MEDICINES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiPraxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)22BOSTON, June 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
► Artikel lesen
MoOppenheimer assigns outperform rating to Praxis Precision Medicines stock1
07.05.Praxis Precision Medicines 'A Diversified Player In Epilepsy Market,' Analyst Sees Over 100% Stock Upside1
PRAXIS PRECISION MEDICINES Aktie jetzt für 0€ handeln
02.05.Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)137BOSTON, May 02, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
► Artikel lesen
02.05.Praxis Precision Medicines GAAP EPS of -$3.291
02.05.Praxis Precision Medicines, Inc. - 10-Q, Quarterly Report2
02.05.Praxis Precision Medicines, Inc. - 8-K, Current Report1
02.05.Praxis Precision Medicines, Inc.: Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2025 Financial Results171On track for six major study readouts across four programs over the next 12 months Ready to initiate pivotal studies in two developmental and epileptic encephalopathy (DEE) programs in mid-year 2025:...
► Artikel lesen
08.04.Praxis Precision Medicines, Inc.: Praxis Precision Medicines to Hold Virtual Investor Event to Discuss Clinical Programs in Developmental and Epileptic Encephalopathies1
08.04.Deep Dive Into Praxis Precision Medicine Stock: Analyst Perspectives (8 Ratings)1
03.04.Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)225BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
► Artikel lesen
24.03.Praxis Precision Medicines, Inc.: Praxis Precision Medicines to Present on Late-Stage Programs across Epilepsy and Movement Disorders at the American Academy of Neurology 2025 Annual Meeting2
04.03.Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)263BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
► Artikel lesen
03.03.Analysts Cut Price Targets For Praxis Precision After Trial Setback For Essential Tremor Candidate1
03.03.Assessing Praxis Precision Medicine: Insights From 5 Financial Analysts3
28.02.Praxis Precision Medicines Plunges 39% After Study Termination Recommendation5
28.02.Praxis Precision Medicines, Inc.: Praxis Precision Medicines Provides Update on Essential3 and Corporate Update345BOSTON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
► Artikel lesen
28.02.Praxis Precision Medicines, Inc. - S-8, Securities to be offered to employees in employee benefit plans-
28.02.Praxis Precision Medicines, Inc. - 10-K, Annual Report-
28.02.Praxis Precision Medicines, Inc. - 8-K, Current Report-
Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1